GlassScriptPhysician profile
Michael A Kelly
NPI 1881634418
$9,665,049.65
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970K · 2020: $864K · 2021: $1.2M · 2022: $1.3M · 2023: $5.3M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.3M.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,286,459.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $9,539,013.12 | 2019-2023 | Persona |
| Think Surgical, INC. | $111,827.53 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $7,384.00 | 2019 | |
| Medical Device Business Services, INC. | $4,690.00 | 2019-2020 | |
| Pacira Therapeutics, INC. | $804.03 | 2019-2021 | |
| Depuy Synthes Sales INC. | $409.25 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $199.87 | 2020 | |
| Limacorporate S.P.A. | $192.32 | 2019 | |
| Nuvasive, INC. | $174.68 | 2021 | |
| Lima USA, INC. | $115.75 | 2019 | |
| Smith+Nephew, INC. | $111.72 | 2019 | |
| Canary Medical USA LLC | $61.44 | 2022 | |
| Kci USA, INC. | $18.52 | 2022 | |
| Medtronic, INC. | $16.76 | 2022 | |
| Heraeus Medical, LLC. | $16.23 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.